Lowe J, Iles P B, Shore D F, Langman M J, Baldwin R W
Lancet. 1980 Jan 5;1(8158):11-4. doi: 10.1016/s0140-6736(80)90551-6.
In a controlled randomised clinical trial of 92 patients with surgically resected lung cancer, intrapleural BCG had no clear effect on survival. Adverse effects were insignificant.
在一项针对92例接受手术切除肺癌患者的对照随机临床试验中,胸膜内注射卡介苗对生存率没有明显影响。不良反应不显著。